Ngành dược thời 4.0
Industry 4.0 is the process of changing production and/or business models, creating new revenue and value by digital transformation with the leverage of third platform technology. Including: mobile computing, social networking, cloud computing (i-cloud computing) and big data packages (big data), internet of things (IoT: internet of things), monitoring technology operations (OT: operational technology), robotics technology, etc. 4 are profoundly affecting all fields, including medicine and pharmacy. 


Many observers argue that the traditional pharmaceutical industry is quite conservative and so a multitude of reasons ranging from regulation to financial resources can be used to justify the delay in adopting new technologies. . However, we will certainly witness dramatic and innovative changes in the pharmaceutical industry in the coming years as Industry 4.0 is becoming a global technological revolution.

Pharmaceutical production in the digital era

  • Process Analysis Technology

In the near future, in pharmaceutical factories, process analysis technology (PAT), will certainly become a reality in modern pharmaceutical factories. There will be hundreds, if not thousands, of smart devices connected, or in the IT term, "embedded" into pharmaceutical manufacturing processes and technologies, to collect data and information in an “on-the-fly” way, for example, SCADA (supervisory control and data acquisition) systems, to replace the traditional performance of quality checks. “Smart pharmaceutical factories” will no longer produce pharmaceutical products in batches, but rather a continuous production process by capable smart devices and tools. machine to machine communication and with the human machine interface).

  • Data processing and security

There will be the digitization of a huge amount of production data that is traditionally still being printed on paper and/or recorded in books. Surely the internet of things will completely revolutionize this work. Thousands of terabytes of electronic data about production/business in factories/companies will be created and stored instead of having to build repositories to store data documents (at the request of manufacturers and regulatory requirements). Pharmaceutical manufacturers and businesses will apply "cloud algorithm" solutions supported by decentralized "block chain" technology that stores information in interconnected data blocks. where system activities will be recorded instantaneously over time. All of these technologies will ensure “data integrity”, “confidentiality” and “data privacy and protection”. The data will be processed intelligently, connected to analytics and integrated with end user information, enabling the production of better quality products, more efficient better efficiency and effectiveness. 


However, like other industries, when applying 4.0 technology, the pharmaceutical industry will also face challenges in terms of security, protection of technological know-how, the integrity of the production process, and the like. production, reduction of human resources...

Currently, due to the complicated development of the Covid-19 epidemic and the risk of a large-scale outbreak, the trend of applying technology 4.0 is accelerating unprecedentedly, creating many breakthroughs in the past time. Remote working processes and automation are no longer a goal but have become an urgent requirement, helping businesses conserve revenue during the pandemic. The future development of Industry 4.0 is clear, but the promotion of its potential depends a lot on the flexibility and effective strategy building of enterprises.